Publications

5802 Results

E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN Cancer Research Group

Authors
RM Connolly;F Zhao;K Miller;M Lee;R Piekarz;K Smith;U Brown-Glaberman;B Faller;AA Onitilo;M Burkard;GT Budd;E Levine;M Royce;P Kaufman;A Thomas;J Trepel;A Wolff;J Sparano
Journal / Conference
Journal of Clinical Oncology, Oct 1;39(28):3171-3181
Year
2021
Research Committee(s)
Breast
PMID
PMID34357781
PMC
PMC8478386
Study Number(s)
CTSU/E2112

Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic

Authors
J Unger;H Xiao;M Leblanc;D Hershman;CD Blanke
Journal / Conference
JAMA Network Open, Jul 1;4(7):e2118433. doi: 10.1001/jamanetworkopen.2021.18433
Year
2021
Research Committee(s)
Cancer Care Delivery and Multiple sites
PMID
PMID34323986
PMC
PMC8323000

Racial Differences in Survival and Response to Therapy in Patients with Metastatic Colorectal Cancer: A Secondary Analysis of CALGB/SWOG 80405 (Alliance A151931)

Authors
R Snyder;J He;J Le-Rademacher;F-S Ou;A Dodge;T Zemla;E Paskett;G Chang;F Innocenti;CD Blanke;H-J Lenz;B Polite;A Venook
Journal / Conference
Journal of Clinical Oncology, Oct 15;127(20):3801-3808
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID34374082
PMC
PMC8478698
Study Number(s)
CTSU/C80405

A Multicenter Phase II Trial (SWOG S1609, Cohort 51) of Ipilimumab and Nivolumab in Metastatic or Unresectable Angiosarcoma: a Sub-Study of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART)

Authors
M Wagner;M Othus;S Patel;C Ryan;A Sangal;B Powers;G Budd;A Victor;C-T Hsueh;R Chugh;S Nair;K Leu;M Agulnik;E Sharon;E Mayerson;M Plets;C Blanke;H Streicher;YK Chae;R Kurzrock
Journal / Conference
Journal for Immunotherapy of Cancer, Aug;9(8):e002990. doi: 10.1136/jitc-2021-002990
Year
2021
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID34380663
PMC
PMC8330584
Study Number(s)
S1609

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Authors
F Rucker;L Du;T Luck;A Benner;J Krzykalla;I Gathmann;T Voso;S Amadori;T Prior;J Brandwein;F Appelbaum;B Medeiros;M Tallman;L Savoie;J Sierra;C Pallaud;M Sanz;J Jansen;D Niederwieser;T Fischer;G Ehninger;M Heuser;A Ganser;L Bullinger;R Larson;C Bloomfield;R Stone;H Dohner;Thiede;C Dohner
Journal / Conference
Leukemia Jul 28. doi: 10.1038/s41375-021-01323-0. Online ahead of print.
Year
2021
Research Committee(s)
Leukemia
PMID
PMID34316017
PMC
PMC8727286
Study Number(s)
CTSU/C10603

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

Authors
A Ruppert;A Booth;W Ding;N Bartlett;D Brander;S Coutre;J Brown;S Nattam;R Larson;H Erba;M Litzow;C Owen;C Kusma;J Abramson;R Little;S Smith;R Stone;J Byrd;S Mandrekar;J Woyach
Journal / Conference
Leukemia, Jul 17. doi: 10.1038/s41375-021-01342-x. Online ahead of print
Year
2021
Research Committee(s)
Leukemia
PMID
PMID34274940
PMC
PMC8744070
Study Number(s)
CTSU/A041202

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group

Authors
B Lacas;A Carmel;C Landais;S Wong;L Licitra;J Tobias;B Burtness;B Burtness;M Ghi;E Cohen;C Grau;G Wolf;R Hitt;R Corvo;V Budach;S Kumar;S Laskar;J Mazeron;L-P Zhong;W Dobrowsky;P Ghadjar;C Fallai;B Zakotnik;A Sharma;R-J Bensadoun;M Redda;S Racadot;G Fountzilas;D Brizel;P Rovea;A Argiris;Z Nagy;J-W Lee;J Portpied;J Harris;J Bourhis;A Auperin;P Blanchard;MACH-NC Group;Collab: J Moon, J Adelstein
Journal / Conference
Radiotherapy and Oncology Mar;156:281-293
Year
2021
Research Committee(s)
Early Therapeutics and Rare Cancers and Head and Neck
PMID
PMID33515668
PMC
PMC8386522
Study Number(s)
SWOG-8006

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Authors
C Petit;B Lacas;J-P Pignon;Q-T Le;V Gregoire;C Grau;A Hackshaw;B Zackrisson;M Parmar;J-W Lee;M Ghi;G Sanguineti;S Teman;M Cheugoua-Zanetsie;B O'Sullivan;M Posner;E Vokes;J Hernandez;Z Szutkowski;E Lartigau;V Budach;R Suwinski;M Poulsen;S Kumar;S Laskar;J-J Mazeron;B Jeremic;J Simes;L-P Zhong;J Overgaard;C Fortpied;P Torres-Saavedra;J Bourhis;A Auperin;P Blanchard;MACH-NC & MARCH Collab Grps;Collab: J Moon, G Wolf;Collab: J Adelstein, A Argiris
Journal / Conference
Lancet Oncology, May;22(5):727-736
Year
2021
Research Committee(s)
Early Therapeutics and Rare Cancers and Head and Neck
PMID
PMID33862002
Study Number(s)
SWOG-8006

Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial

Authors
O Rahma;G Yothers;T Hong;M Russell;Y You;W Parker;S Jacobs;L Colangelo;P Lucas;M Gollub;W Hall;L Kachnic;N Vijayvergia;M O'Rourke;B Faller;R Valicenti;T Schefter;K Moxley;R Kainthla;P Stella;E Sigurdson;N Wolmark
Journal / Conference
JAMA Oncology, Aug 1;7(8):1225-1230
Year
2021
Research Committee(s)
Gastrointestinal
PMID
PMID34196693
PMC
PMC8251652
Study Number(s)
CTSU/NRG-GI002

The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy

Authors
R Hamilton;K Ding;J Crook;C O'Callaghan;C Higano;R Dearnaley;E Horwitz;S Goldenberg;M Gospodarowicz;L Klotz
Journal / Conference
European Urology, Apr;79(4):446-452
Year
2021
Research Committee(s)
Genitourinary
PMID
PMID33390282
Study Number(s)
JPR7